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A B S T R A C T   
Background: The unprecedented worldwide crisis caused by the rapid spread of COVID-19 and the restrictive 
public health measures enforced by some countries to slow down its transmission have severely threatened the 
physical and mental wellbeing of communities globally. 
Methods: We conducted a systematic review and meta-analysis to determine the prevalence of anxiety in the 
general population during the COVID-19 pandemic. Two researchers independently searched for cross-sectional 
community-based studies published between December 1, 2019 and August 23, 2020, using PubMed, WoS, 
Embase, and other sources (e.g., grey literature, manual search). 
Results: Of 3049 records retrieved, 43 studies were included. These studies yielded an estimated overall preva-
lence of anxiety of 25%, which varied significantly across the different tools used to measure anxiety. Consis-
tently reported risk factors for the development of anxiety included initial or peak phase of the outbreak, female 
sex, younger age, marriage, social isolation, unemployment and student status, financial hardship, low educa-
tional level, insufficient knowledge of COVID-19, epidemiological or clinical risk of disease and some lifestyle 
and personality variables. 
Conclusions: As the overall global prevalence of anxiety disorders is estimated to be 7.3% normally, our results 
suggest that rates of anxiety in the general population could be more than 3 times higher during the COVID-19 
pandemic. These findings suggest a substantial impact on mental health that should be targeted by individual and 
population-level strategies.   
1. Introduction 
COVID-19, the coronavirus-transmitted infectious disease, was first 
identified in Wuhan, China, and declared a pandemic by the World 
Health Organization on March 11, 2020 (WHO, 2020a). To date 
(September 7th, 2020), there have been 27.032.617 confirmed cases of 
COVID-19 worldwide, from which 881.464 people have died (WHO, 
2020b). Public health measures designed to slow down or prevent the 
Abbreviations: COVID-19, coronavirus infectious disease 2019; SARS-CoV-1, severe acute respiratory syndrome coronavirus 1; MERS-CoV, Middle East respiratory 
syndrome coronavirus; GAD, Generalized Anxiety Disorder scale; DASS, Depression Anxiety and Stress Scale; SAS, Zung Self-rating Anxiety Scale; STAI, State-Trait 
Anxiety Inventory; BAI, Beck Anxiety Inventory; HADS, Anxiety and Depression Scale; BSI-53, Brief Symptom Inventory-53. 
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spread of COVID-19 have deeply changed our lifestyle and threatened 
our physical and mental wellbeing, with a restriction of freedom and 
large economic losses. 
The psychological impact of previous epidemic outbreaks on the 
general public is relatively understudied, as most research has focused 
on frontline health workers and patients. Nonetheless, many stressors 
have been linked to disease outbreaks and pandemics. In early stages, 
this includes the unpredictable nature of the disease and lack of clarity 
about the seriousness of the risk, as well as concern about the health and 
isolation of oneself and one’s family and loved ones (Huremović, 2019; 
Zandifar and Badrfam, 2020). Similarly, the severity of the disease 
outcome, its transmissibility and the presence of public fatigue due to 
prolonged pandemic warnings in those areas suffering from several virus 
outbreaks are sources of variability in the public psychological response 
in past outbreaks (Chan et al., 2015). Thus, negative mental health 
outcomes (i.e., posttraumatic stress, depression, and avoidance behav-
iors) were reported during the SARS-CoV-1 outbreak in 2003 in Toronto, 
Singapore and Hong Kong, where strict infection-containment measures 
were enforced on the population, including quarantine (Hawryluck 
et al., 2004; Lau et al., 2006; Lau et al., 2005; Sim et al., 2010), whereas 
low anxiety levels were found for the A/H5N1 avian, A/H1N1 and H7N9 
influenza (Bults et al., 2015; Chan et al., 2015) and Ebola (Quian Hui 
et al., 2020) epidemics in most areas, possibly due to lower infection 
rates and quick disease containment, respectively (Huremović, 2019). 
Likewise, anxiety symptoms and feelings of anger were present in 
noninfected but quarantined individuals during the MERS-CoV outbreak 
in 2015 (Jeong et al., 2016). 
In the current situational framework, the rapid spread and number of 
deaths caused by COVID-19, the imposition of home confinement for 
indefinite periods of time, and the growing financial losses can convey 
an increased risk for psychiatric conditions among all layers of society 
(Pfefferbaum and North, 2020). In fact, several systematic reviews and 
meta-analyses have been published, revealing increased stress, post- 
traumatic stress disorder (PTSD), anxiety, and depression in health-
care workers (Chew et al., 2020), higher risk of distress, anxiety, 
depression, and sleep disturbance in nurses (Rasmussen, 2020), and a 7- 
fold increase in depression rates in the general population (Bueno- 
Notivol et al., 2020). 
Previous reviews have been published with data on anxiety and 
COVID-19 in the general population. However, one review covered 
epidemic outbreaks since 2007 and included only one study on COVID- 
19 (Fardin, 2020), and the other one included only two Chinese studies 
conducted in the general population (Rajkumar, 2020). These reviews 
were followed by a systematic review and meta-analysis published in 
July 2020 (Salari et al., 2020), which reported a prevalence of anxiety in 
the general population of 32%. However, several studies on the preva-
lence of anxiety have been published afterward, which highlights the 
pertinence of an updated meta-analysis on this topic. Therefore, this 
study aims to conduct a systematic review and meta-analysis to ascertain 
the impact of the COVID-19 outbreak on the prevalence of anxiety in the 
general population. 
2. Materials and methods 
This study was conducted following the PRISMA guidelines for 
reporting systematic reviews and meta-analyses (Moher et al., 2009) 
(Supplementary Table 1). 
2.1. Search strategy 
Two researchers (JBN and IL) searched for all cross-sectional studies 
reporting the prevalence of anxiety published from December 1, 2019, 
to June 15, 2020, using MEDLINE via PubMed, Web of Science, and 
Embase. The search strategies are shown in Table 1. No language re-
striction was made. References from selected articles were inspected to 
detect additional potential studies. We then performed a manual search 
of the “grey literature” (e.g., medRxiv) to detect other potentially 
eligible investigations. Any disagreement was resolved by consensus 
among a third and fourth reviewer (JS and PGG). This search was 
updated on August 23, 2020. 
2.2. Selection criteria 
Studies were included if: (1) they reported cross-sectional data on the 
prevalence of anxiety during the COVID-19 outbreak; (2) they were 
focused on community-based samples; (3) they described the methods 
used to assess or diagnose anxiety; (4) the full-text was available. We 
excluded studies focusing on specific samples (e.g., medical pro-
fessionals, patients), and review articles. 
A pre-designed data extraction form was used to extract information 
on the following: country, sample size, prevalent rates of anxiety, pro-
portion of women, average age, instruments used to assess anxiety, 
response rate, and sampling methods. 
2.3. Methodological quality assessment 
Articles selected for retrieval were assessed by two independent re-
viewers (JBN and JS) for methodological validity before they were 
included in the review, using the Joanna Briggs Institute (JBI) stan-
dardized critical appraisal instrument for prevalence studies (Moola 
et al., 2017). Quality was evaluated according to nine criteria, each 
yielding a score of zero or one. One score was obtained for each criterion 
if the study was affirmative in the next questions: 1: Was the sample 
frame appropriate to address the target population? 2: Were study 
participants recruited appropriately? 3: Was the sample size adequate? 
4: Were the study subjects and setting described in detail? 5: Was data 
analysis conducted with sufficient coverage of the identified sample? 6: 
Were valid methods used for the identification of the condition? 7: Was 
the condition measured in a standard, reliable way for all participants? 
8: Was the statistical analysis appropriate? 9: Was the response rate 
adequate, and if not, was the low response rate managed appropriately? 
Any disagreements that arose between the reviewers were resolved 
through discussions, or by further discussion with a third reviewer 
(PGG). 
2.4. Data extraction and statistical analysis 
A generic inverse variance method with a random effect model was 
used (DerSimonian and Laird, 1986) and the I2 statistic and 95% con-
fidence interval were employed to quantify heterogeneity (von Hippel, 
2015). I2 values between 25%–50% are considered as low, 50%–75% as 
moderate, and 75% or more as high (Higgins et al., 2003). Heterogeneity 
Table 1 
Search strategies.  
MEDLINE vía PubMed: 
(covid or covid-19 OR coronavirus OR “corona virus” OR SARSCoV-2 OR 
“Coronavirus”[Mesh] OR “severe acute respiratory syndrome coronavirus 
2”[Supplementary Concept] OR “COVID-19”[Supplementary Concept] OR 
“Coronavirus Infections/epidemiology”[Mesh] OR “Coronavirus Infections/ 
prevention and control”[Mesh] OR “Coronavirus Infections/psychology”[Mesh] OR 
“Coronavirus Infections/statistics and numerical data”[Mesh]) AND (anxiety OR 
anxiety symptoms OR anxiety disorders OR anxious OR “Trauma and Stressor 
Related Disorders”[Mesh] OR “Anxiety”[Mesh] OR “Anxiety Disorders”[Mesh] OR 
“Anxiety/epidemiology”[Mesh] OR “Anxiety/statistics and numerical data”[Mesh]) 
Web of Science: 
ALL = (covid or covid-19 OR coronavirus OR “corona virus” OR SARSCoV-2 OR 
“severe acute respiratory syndrome coronavirus 2”) AND ALL = (anxiety OR 
“anxiety symptoms” OR “anxiety disorders” OR anxious OR trauma) 
Embase: 
(covid:ab,ti OR ‘covid 19’:ab,ti OR coronavirus:ab,ti OR ‘corona virus’:ab,ti OR 
‘sarscov 2’:ab,ti OR ‘severe acute respiratory syndrome coronavirus 2’:ab,ti) AND 
(anxiety:ab,ti OR ‘anxiety symptoms’:ab,ti OR ‘anxiety disorders’:ab,ti OR anxious: 
ab,ti OR trauma:ab,ti) AND [2019–2020]/py  
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of effects between studies occurs when differences in results for the same 
exposure-disease association cannot be fully explained by sampling 
variation. Sources of heterogeneity can include differences in study 
design or in demographic characteristics. We performed meta-regression 
and subgroup analyses (Thompson and Higgins, 2002) to explore the 
sources of heterogeneity expected in meta-analyses of observational 
studies (Egger et al., 1998). We conducted a sensitivity analysis to 
determine the influence of each individual study on the overall result by 
omitting studies one by one. Publication bias was determined through 
visual inspection of a funnel plot and also Egger (Egger et al., 1997) and 
Begg tests (Begg and Mazumdar, 1994) (p values <0.05 indicate publi-
cation bias) since because funnel plots were found to be an inaccurate 
method for assessing publication bias in meta-analyses of proportion 
studies (Hunter et al., 2014). 
Statistical analyses were conducted by JS and run with STATA sta-
tistical software (version 10.0; College Station, TX, USA) and R (R Core 
Team, 2019). 
3. Results 
3.1. Identification and selection of articles 
Fig. 1 shows a flow chart of the literature search strategy and study 
selection process up to 23 August 2020. Initially, 1017 potential records 
were identified in multiple databases, to which 2032 records were added 
in the August 23 update. After removing 382 duplicate items in June and 
867 in August (n = 1249), 635 and 1165 items were respectively iden-
tified for selection (n = 1800). The titles and abstracts of these articles 
were read and 564 articles in June and 1071 in August were excluded for 
failure to meet the inclusion criteria (n = 1635). To the remaining 165 
articles (71 in June and 94 in August) was added 1 more found by 
manual search of other databases and reference lists. After reading the 
remaining 72 articles in June and 94 in August (n = 166), we included 
15 and 28 articles in our study, respectively (n = 43). (Ahmed et al., 
2020a; Alkhamees et al., 2020; Arafa et al., 2020; Ayhan Başer et al., 
2020; Al Banna et al., 2020; Bäuerle et al., 2020; Choi et al., 2020; 
Cortés-Álvarez et al., 2020; Elhai et al., 2020; Fernández et al., 2020; 
Forte et al., 2020; Fu et al., 2020; Fullana et al., 2020; Galindo-Vázquez 
et al., 2020; Gao et al., 2020; Horesh et al., 2020; Huang and Zhao, 2020; 
Huarcaya-Victoria et al., 2020; Hyland et al., 2020; Islam et al., 2020; 
Kazmi et al., 2020; Lei et al., 2020; Liu et al., 2020; Moghanibashi- 
Mansourieh, 2020; Newby et al., 2020; Orellana and Orellana, 2020; 
Ozamiz-Etxebarria et al., 2020; Özdin and Bayrak Özdin, 2020; Palgi 
et al., 2020; Papandreou et al., 2020; Paulino et al., 2020; Pieh et al., 
2020; Rettie and Daniels, 2020; Rodríguez-Rey et al., 2020; Shevlin 
et al., 2020; Shi et al., 2020; Solomou and Constantinidou, 2020; Stan-
ton et al., 2020; Verma and Mishra, 2020; C. Wang et al., 2020a; Y. Wang 
et al., 2020; Zhao et al., 2020). 
3.2. Characteristics of the studies included 
The characteristics of the 43 included studies are summarized in 
Fig. 1. Flowchart of the study selection.  
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Table 2 
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Table 2. They reported 44 prevalence rates (2 from one study (Papan-
dreou et al., 2020)), making a total of 161,556 individuals. Regarding 
study location, China was the most frequent country with 13 studies 
(Ahmed et al., 2020a; Choi et al., 2020; Elhai et al., 2020; Fu et al., 2020; 
Gao et al., 2020; Guo et al., 2020; Huang and Zhao, 2020; Lei et al., 
2020; Liu et al., 2020; Shi et al., 2020; C. Wang et al., 2020a; Y. Wang 
et al., 2020; Zhao et al., 2020), followed by 12 European studies (Bäuerle 
et al., 2020; Forte et al., 2020; Fullana et al., 2020; Hyland et al., 2020; 
Ozamiz-Etxebarria et al., 2020; Papandreou et al., 2020; Paulino et al., 
2020; Pieh et al., 2020; Rettie and Daniels, 2020; Rodríguez-Rey et al., 
2020; Shevlin et al., 2020; Solomou and Constantinidou, 2020), 7 
Middle Eastern studies (Alkhamees et al., 2020; Arafa et al., 2020; 
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Ayhan Başer et al., 2020; Horesh et al., 2020; Moghanibashi-Mansour-
ieh, 2020; Özdin and Bayrak Özdin, 2020; Palgi et al., 2020), 4 Central 
and South American studies(Cortés-Álvarez et al., 2020; Fernández 
et al., 2020; Galindo-Vázquez et al., 2020; Huarcaya-Victoria et al., 
2020; Orellana and Orellana, 2020), 5 South Asian studies (Al Banna 
et al., 2020; Islam et al., 2020; Kazmi et al., 2020; Verma and Mishra, 
2020) and 2 Australian studies (Newby et al., 2020; Stanton et al., 
2020). The sample size ranged from 204 to 56,679 participants, and the 
mean age ranged from 23.54 ± 5 years to 50.5 ± 14.9 years in the 
twenty-nine studies that did report it. All studies included both men and 
women, and the percentage of women was over 50% in 39 of the 44 
studies, ranging from 28.5% to 85.8%. All studies were conducted using 
online questionnaires, and all but two (Choi et al., 2020; Kazmi et al., 
2020) carried out non-randomised sampling. 26 studies reported the 
response rate, which averaged out at 89.81 and ranged from 64.6% to 
99.6%. All studies measured anxiety using symptom-based scales: 17 
used the Generalized Anxiety Disorder scale (GAD) (Bäuerle et al., 2020; 
Choi et al., 2020; Fu et al., 2020; Fullana et al., 2020; Galindo-Vázquez 
et al., 2020; Gao et al., 2020; Huang and Zhao, 2020; Huarcaya-Victoria 
et al., 2020; Hyland et al., 2020; Islam et al., 2020; Palgi et al., 2020; 
Fig. 2. Forest plot of the prevalence of anxiety.  
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Papandreou et al., 2020; Pieh et al., 2020; Rettie and Daniels, 2020; 
Shevlin et al., 2020; Shi et al., 2020; Solomou and Constantinidou, 
2020), 15 used the Depression, Anxiety and Stress Scale (DASS) 
(Alkhamees et al., 2020; Arafa et al., 2020; Al Banna et al., 2020; Cortés- 
Álvarez et al., 2020; Elhai et al., 2020; Kazmi et al., 2020; Moghaniba-
shi-Mansourieh, 2020; Newby et al., 2020; Orellana and Orellana, 2020; 
Ozamiz-Etxebarria et al., 2020; Paulino et al., 2020; Rodríguez-Rey 
et al., 2020; Stanton et al., 2020; Verma and Mishra, 2020; C. Wang 
et al., 2020a), 2 used the Zung Self-rating Anxiety Scale (SAS) (Lei et al., 
2020; Y. Wang et al., 2020), 2 used State-Trait Anxiety Inventory (STAI) 
(Forte et al., 2020; Liu et al., 2020), 4 used the Beck Anxiety Inventory 
(BAI) (Ahmed et al., 2020b; Ayhan Başer et al., 2020; Horesh et al., 
2020; Zhao et al., 2020), 2 used Hospital Anxiety and Depression Scale 
(HADS) (Guo et al., 2020; Özdin and Bayrak Özdin, 2020) and one used 
Brief Symptom Inventory-53 (BSI-53) (Fernández et al., 2020). The re-
ported cut-off points used to classify anxiety are shown in Table 2. The 
studies reported highly diverse values of anxiety prevalence, ranging 
from 6.33% to 53.50%. 
3.3. Quality assessment 
The risk of bias scores ranged from 6 to 9 out of a possible total of 9, 
with a mean score of 7.3 (Supplementary Table 2). The most common 
limitations were: (a) sampling and recruitment of participants not 
appropriate or not specified and (b) response rate not reported, or large 
number of non-responders. 
3.4. Meta-analysis of the prevalence of anxiety 
The estimated overall prevalence of anxiety was 25% (95% CI: 21%– 
29%), with significant heterogeneity between studies (I2 = 99.7%, p <
0.001) (Fig. 2). 
3.5. Meta-regression 
Our meta-regression showed that prevalence of anxiety was inde-
pendent of a study’s percentage of women (p = 0.980), mean age at 
baseline (p = 0.102), response rate (p = 0.848), or methodological 
quality (p = 0.950). 
3.6. Subgroup analysis 
Neither study location nor sampling method was a significant 
moderator according to subgroup analysis. The only significant finding 
was a lower prevalence of anxiety for studies using the SAS (8% [95% CI: 
7%–9%]) (Lei et al., 2020; Y. Wang et al., 2020) compared to those using 
the BAI (18% [95% CI: 9%–30%]) (Arafa et al., 2020; Ayhan Başer et al., 
2020; Horesh et al., 2020; Zhao et al., 2020), the GAD (21% [95% CI: 
17%–26%]) (Bäuerle et al., 2020; Choi et al., 2020; Fu et al., 2020; 
Fullana et al., 2020; Galindo-Vázquez et al., 2020; Gao et al., 2020; 
Huang and Zhao, 2020; Huarcaya-Victoria et al., 2020; Hyland et al., 
2020; Islam et al., 2020; Palgi et al., 2020; Papandreou et al., 2020; Pieh 
et al., 2020; Rettie and Daniels, 2020; Shevlin et al., 2020; Shi et al., 
2020; Solomou and Constantinidou, 2020), the HADS (28% [95% CI: 
26%–29%]) (Guo et al., 2020; Özdin and Bayrak Özdin, 2020), the DASS 
(32% [95% CI: 24%–41%]) (Alkhamees et al., 2020; Arafa et al., 2020; 
Al Banna et al., 2020; Cortés-Álvarez et al., 2020; Elhai et al., 2020; 
Kazmi et al., 2020; Moghanibashi-Mansourieh, 2020; Newby et al., 
2020; Orellana and Orellana, 2020; Ozamiz-Etxebarria et al., 2020; 
Paulino et al., 2020; Rodríguez-Rey et al., 2020; Stanton et al., 2020; 
Verma and Mishra, 2020; C. Wang et al., 2020a) or BSI (32% [95% CI: 
30%–33%]) (Fernández et al., 2020), and the STAI (33% [95% CI: 31%– 
34%]) (Forte et al., 2020; Liu et al., 2020). 
3.7. Sensitive analysis 
Excluding each study one-by-one from the analysis did not sub-
stantially change the pooled prevalence of anxiety, which varied be-
tween 24% (95% CI: 20% - 29%), with Arafa et al. (2020) excluded, to 
25% (95% CI: 21% - 30%), with Y. Wang et al. (2020) excluded. This 
indicates that no single study had a disproportional impact on the 
overall prevalence. 
3.8. Risk of publication bias 
Visual inspection of the funnel plot (Supplementary Fig. 1) suggested 
no presence of publication bias for the estimate of prevalence, confirmed 
by non-significant Begg (p = 0.059) and Egger (p = 0.119) test results. 
4. Discussion 
4.1. Main findings 
The present meta-analysis of 43 large studies finds that the preva-
lence of anxiety in the general population during the COVID-19 
outbreak is 25% (95% CI 21%–29%). 
The main source of heterogeneity in rates of anxiety between studies 
was the scale used to assess anxiety, with the highest rates for studies 
using the DASS-21 and the lowest rates for studies using the SAS. This is 
consistent with the cut-off point in the SAS used for classifying anxiety in 
these studies (SAS 50+) having a much lower sensitivity (31%) than the 
diagnostic sensitivity of the DASS (74% for mild anxiety) (Dunstan et al., 
2017). 
4.2. Comparison with previous epidemiological data 
Given that the overall prevalence of anxiety disorders around the 
globe is estimated to be normally around 7.3% (95% CI: 4.8% to 10.9%) 
(Stein et al., 2017), our results suggest that rates of anxiety in the general 
population could be more than 3 times higher during the COVID-19 
outbreak. 
The reported rates of anxiety in the general population during pre-
vious epidemic outbreaks (Severe Acute Respiratory Syndrome, SARS; 
H1N1 influenza, Ebola) ranged between 3.2% and 12.6% (Chew et al., 
2020), which is lower than the rates of anxiety during COVID-19 that we 
have identified here. This could be because in past epidemics, despite 
higher fatality rates, infection rates were lower (such as H1N1 influenza, 
in 2009–2010) or the disease was quickly contained (such as Ebola, in 
2014–2016) (Huremović, 2019). Long and undetermined periods of 
lockdown imposed by governments around the world could be 
contributing to higher rates of anxiety during COVID-19, consistent with 
the negative psychological effects of quarantine reported during the 
SARS outbreak in Toronto, Canada (Hawryluck et al., 2004). A previous 
meta-analysis (Salari et al., 2020) of the prevalence of anxiety in general 
population during the COVID-19 pandemic, including 17 studies, found 
even higher rates of anxiety than ours (31.9% (95%CI 27.5 to 36.7%)). A 
potential explanation for these differences might be that Asiatic samples 
were overrepresented and European samples underrepresented in 
comparison with our study. They found similar rates of anxiety that our 
meta-analysis when they analyzed separately European studies (23.8% 
(95%CI 16.2 to 33.5%)) (Salari et al., 2020). 
4.3. Asociation between anxiety levels and COVID-19 relevant factors 
4.3.1. Time point of data collection 
In the studies herein assessed, data were collected from January 7th 
to May 7th, coinciding with different time points of the pandemic in 
their respective areas, as represented in Fig. 3. As previous evidence on 
the H1N1 epidemic shows, anxiety tends to reach its highest point at the 
peak of the epidemic, then waning in concert with its decline (Liao et al., 
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2014). Thus, disparities in time of data collection could account for some 
of the heterogeneity among the prevalence values retrieved. For 
example, a Spanish study examining anxiety prevalence between March 
11th and 18th (right before the declaration of the state of alarm and the 
imposition of mandatory quarantine) and April 2nd and 12th, found 
significantly higher scores for depression, anxiety, and stress symptoms 
during the second time interval, when the curve had a negative slope 
(Ozamiz-Etxebarria et al., 2020). Similar trends can be observed when 
comparing the studies conducted in the United Kingdom (Rettie and 
Daniels, 2020; Shevlin et al., 2020), Turkey (Ayhan Başer et al., 2020; 
Özdin and Bayrak Özdin, 2020) and Australia (Newby et al., 2020; 
Stanton et al., 2020) (see Fig. 3b,c,f). With regard to Chinese studies (see 
Fig. 3a), juxtaposition may be equivocal, as three of the studies carried 
out at the peak of the pandemic use tools of lower sensitivity, as has been 
explained above (Lei et al., 2020; Y. Wang et al., 2020; Zhao et al., 
2020). Variance may also stem from the different provinces assessed. 
Even so, the high anxiety levels during the initial phase of the pandemic 
can be attributed to a higher degree of uncertainty regarding COVID-19 
Fig. 3. Time point of data collection in the different studies within the epidemic curve of the pandemic in their respective countries. Epidemic curves show a linear 
depiction of the daily new cases of COVID-19 and the data indicate the total number of confirmed cases the day the study began. Adapted from existing graphs from 
Our World in Data (https://ourworldindata.org/coronavirus) (Roser et al., 2020). (a) Chinese studies (blue) and their prevalence of anxiety (orange). (b) European 
studies. (c) Middle East studies. (d) South Asian studies. (e) Central and South American studies. (f) Australian studies (blue) and their prevalence of anxiety (orange). 
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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because the first study revealed that nearly all respondents desired 
additional information about the disease (C. Wang et al., 2020a). High 
anxiety levels are expected to remain high, or even increase as the 
epidemic spreads, consistent with findings of C. Wang et al., who found 
no significant difference in the anxiety levels of two separate samples of 
the Chinese general population at different time points, the first during 
the initial outbreak and the second during the epidemic’s peak four 
weeks later (C. Wang et al., 2020a, 2020b). Contrarily, a decreasing 
trend can be observed for those studies taking place after the pandemic 
had peaked (Choi et al., 2020; Elhai et al., 2020; Fu et al., 2020; Guo 
et al., 2020; Shi et al., 2020). 
4.3.2. Sex 
Most studies show significantly higher anxiety levels in women 
(Alkhamees et al., 2020; Arafa et al., 2020; Ayhan Başer et al., 2020; Al 
Banna et al., 2020; Bäuerle et al., 2020; Cortés-Álvarez et al., 2020; 
Fernández et al., 2020; Forte et al., 2020; Fu et al., 2020; Fullana et al., 
2020; Galindo-Vázquez et al., 2020; Gao et al., 2020; Guo et al., 2020; 
Horesh et al., 2020; Huang and Zhao, 2020; Huarcaya-Victoria et al., 
2020; Hyland et al., 2020; Islam et al., 2020; Kazmi et al., 2020; Lei 
et al., 2020; Liu et al., 2020; Moghanibashi-Mansourieh, 2020; Newby 
et al., 2020; Orellana and Orellana, 2020; Ozamiz-Etxebarria et al., 
2020; Özdin and Bayrak Özdin, 2020; Palgi et al., 2020; Papandreou 
et al., 2020; Paulino et al., 2020; Pieh et al., 2020; Rettie and Daniels, 
2020; Rodríguez-Rey et al., 2020; Shevlin et al., 2020; Shi et al., 2020; 
Solomou and Constantinidou, 2020; Stanton et al., 2020; C. Wang et al., 
2020a; Y. Wang et al., 2020; Zhao et al., 2020). This is consistent with 
previous epidemiological data (Bandelow and Michaelis, 2015). 
Many arguments have been put forward to justify this finding. First, 
females are socialized to more openly and strongly experience their 
emotions (Fu et al., 2020). Second, differences in brain chemistry and 
hormones between men and women have been hypothesized to mediate 
the higher anxiety rates in females (Fu et al., 2020; Stanikova et al., 
2019). Third, women are usually the main caregivers within families, 
which could make them more vulnerable to the increased burden at 
home following the closure of schools and other facilities (Rodríguez- 
Rey et al., 2020). In this sense, one study found that women perceived a 
stronger deterioration of family ties during the quarantine, which 
correlated with a greater perception of their routine being altered 
(Orellana and Orellana, 2020), and the two Bangladeshi studies reported 
the greatest anxiety levels for housewives (Al Banna et al., 2020; Islam 
et al., 2020). In another study, women showed higher stress levels than 
men (Stanton et al., 2020). This could substantially reduce a woman’s 
ability to perform their work, hindering their economic stability 
(Rodríguez-Rey et al., 2020), which can also explain why, in one study, 
women showed higher levels of worry about the effect of the virus on 
their financial status (Horesh et al., 2020). Fourth, feelings of anxiety 
could be mediated by an increased psychological impact of COVID-19 
(Paulino et al., 2020; Shevlin et al., 2020), possibly due to an intensi-
fied fear of the virus and worry about close relatives and friends being 
infected (Horesh et al., 2020). In one study, however, females only 
scored higher for general anxiety, not COVID-19 anxiety (Hyland et al., 
2020), and another study reported increased anxiety scores in men (C. 
Wang et al., 2020a). This could be related to lower compliance with 
precautionary measures (Solomou and Constantinidou, 2020), more 
frequency of risky behaviors (e.g., going to crowded places or not 
wearing masks), or a higher infective rate in males (Shi et al., 2020). 
Finally, many studies concluded that women were also at a higher risk of 
developing depression during the pandemic (Salari et al., 2020), which 
is a risk factor for anxiety (Jacobson and Newman, 2017). Nevertheless, 
in one case, higher female higher levels of anxiety remained present, 
even though stress and depression where higher in males (Kazmi et al., 
2020). 
4.3.3. Age 
Increased rates of anxiety were also consistently found to be 
associated with younger age (Ahmed et al., 2020b; Alkhamees et al., 
2020; Al Banna et al., 2020; Bäuerle et al., 2020; Cortés-Álvarez et al., 
2020; Fernández et al., 2020; Forte et al., 2020; Fullana et al., 2020; Guo 
et al., 2020; Horesh et al., 2020; Huang and Zhao, 2020; Hyland et al., 
2020; Islam et al., 2020; Kazmi et al., 2020; Lei et al., 2020; Liu et al., 
2020; Moghanibashi-Mansourieh, 2020; Newby et al., 2020; Orellana 
and Orellana, 2020; Ozamiz-Etxebarria et al., 2020; Palgi et al., 2020; 
Paulino et al., 2020; Pieh et al., 2020; Rettie and Daniels, 2020; Rodrí-
guez-Rey et al., 2020; Shi et al., 2020; Solomou and Constantinidou, 
2020; Stanton et al., 2020; Y. Wang et al., 2020; Zhao et al., 2020). This 
may stem from uncertainty about the future of jobs and careers (Kazmi 
et al., 2020), as younger individuals also show more financial worries 
(Horesh et al., 2020),; or because this segment of the population tends to 
collect information from social media (Ahmed et al., 2020b; Elhai et al., 
2020; Liu et al., 2020). Whereas younger participants’ excessive 
smartphone use appeared to be driven by increased every-day anxiety 
(e.g. financial worry, worry about social and intimate relationship for-
mation and maintenance, missing out on rewarding experiences, etc.), 
rather than worry about COVID-19 itself (Elhai et al., 2020), which was 
higher among older individuals (Hyland et al., 2020; Shevlin et al., 
2020), it can also reinforce their anxiety. For instance, being frequently 
exposed to social media or following coronavirus news for more than 2 
or 3 h per day was found to increase the odds of anxiety up to 3 times 
(Arafa et al., 2020; Fullana et al., 2020; Gao et al., 2020; Huang and 
Zhao, 2020; Moghanibashi-Mansourieh, 2020; Rodríguez-Rey et al., 
2020). This is consistent with “emotional epidemiology” defined by Ofri: 
social media can generate immediate flooding of fear during the rapid 
spread of a disease, independent of real risk (Ofri, 2009). 
4.3.4. Marital status, living arrangements, and social support 
The effect of civil status on anxiety varied from study to study, 
possibly due to cultural differences. In two Chinese reports, anxiety was 
highest in individuals who were divorced or widowed (Lei et al., 2020; 
Zhao et al., 2020), whereas in one Australian and another Spanish study, 
this group was surpassed by those who had never been married, or those 
who were in a relationship but not cohabiting (Rodríguez-Rey et al., 
2020; Stanton et al., 2020). 
Most of the studies investigating marital status found increased 
anxiety in married residents compared to their unmarried counterparts 
(Al Banna et al., 2020; Fu et al., 2020; Gao et al., 2020; Islam et al., 2020; 
Palgi et al., 2020; Zhao et al., 2020). One reason for this could be an 
increased sense of responsibility for their families, for married partici-
pants tended to worry about their family members’ health instead of 
themselves (Fu et al., 2020). Higher anxiety levels in married partici-
pants could also be related to household size, although this effect is not 
homogeneous, For example, two studies reported higher anxiety for 
subjects with children (Fullana et al., 2020; Shevlin et al., 2020), and 
another one for individuals living with more than 3 people (Solomou 
and Constantinidou, 2020). On the other hand, one Spanish study found 
that having children mitigated anxiety levels only for those who had two 
or fewer children, whose children were over 10 years old or who did not 
live with them (Rodríguez-Rey et al., 2020). This is likely to be due to 
increased family burden with the closure of schools and increased family 
conflicts in areas where mandatory confinement gathers several people 
under the same roof (Guo et al., 2020; Orellana and Orellana, 2020). 
Interestingly, people whose houses’ were sized was more than 120 
square meters and had open-air space showed lower psychological 
impact, stress, anxiety, and depression (Rodríguez-Rey et al., 2020). 
Finally, it is noteworthy to mention that the negative effect of mar-
riage and uninterrupted cohabitation on anxiety might be reduced by 
the protective effect of marriage on depression (Cortés-Álvarez et al., 
2020; Galindo-Vázquez et al., 2020; Hyland et al., 2020; Lei et al., 2020; 
Shi et al., 2020), which provides a rationale for why increased anxiety in 
married respondents did not reach significant levels in some cases 
(Alkhamees et al., 2020; Cortés-Álvarez et al., 2020; Fernández et al., 
2020; Horesh et al., 2020; Lei et al., 2020; Moghanibashi-Mansourieh, 
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2020; Özdin and Bayrak Özdin, 2020; Shi et al., 2020; Verma and Mis-
hra, 2020; C. Wang et al., 2020a). In this sense, several studies reported 
that feelings of loneliness and lack of social support were among the 
strongest correlators with anxiety during the pandemic (Arafa et al., 
2020; Fullana et al., 2020; Horesh et al., 2020; Newby et al., 2020; Palgi 
et al., 2020), which is in line with previous research showing that social 
isolation influences negative affectivity (Elhai et al., 2020). Remarkably, 
anxiety was found to be reduced by communicating frequently through 
online video, which should be encouraged in times of social isolation (Fu 
et al., 2020). 
4.3.5. Occupational status and financial stability 
Anxiety appeared to reach higher levels among unemployed in-
dividuals and those who had not been able to return to work or work 
from home when confinement was imposed (Al Banna et al., 2020; Choi 
et al., 2020; Kazmi et al., 2020; Papandreou et al., 2020; Paulino et al., 
2020; Pieh et al., 2020; Shi et al., 2020; Solomou and Constantinidou, 
2020), as well as those who perceived a high risk of job loss or had 
suffered loss of income due to COVID-19 (Fullana et al., 2020; Guo et al., 
2020; Hyland et al., 2020; Lei et al., 2020; Rodríguez-Rey et al., 2020; 
Shevlin et al., 2020). The lack of work can not only affect a person’s 
financial stability, which is a predictor of anxiety, but can also affect the 
psycho-social functioning of individuals through a lack of daily routine 
and scheduling (Kazmi et al., 2020). 
Furthermore, individuals who were teleworking showed less psy-
chological impact and anxiety than those working in their ordinary 
workplace (Paulino et al., 2020; Rodríguez-Rey et al., 2020). 
High levels of anxiety and distress were also found in Saudi Arabian, 
Salvadorian, Chinese, and Spanish students (Alkhamees et al., 2020; Lei 
et al., 2020; Liu et al., 2020; Orellana and Orellana, 2020; Rodríguez- 
Rey et al., 2020; C. Wang et al., 2020a), but not in Portuguese or Ban-
gladeshi students (Al Banna et al., 2020; Islam et al., 2020; Paulino et al., 
2020). It is likely that the relationship between student status and 
anxiety is mediated by age. Interestingly, an opposite tendency was 
found for anxiety in Medicine students, whose greater perceived suffi-
ciency of information on COVID-19’s prognosis and transmission and 
higher use of reliable sources of information, rather than social media 
alone (Saddik, 2020) have been hypothesized to act as protective factors 
against anxiety (Lasheras et al., 2020). 
In addition, the majority of studies did not find any significant dif-
ferences between anxiety levels in frontline health workers and the rest 
(Alkhamees et al., 2020; Forte et al., 2020; Huang and Zhao, 2020; Shi 
et al., 2020; Solomou and Constantinidou, 2020). It is possible that the 
effect on anxiety of poor sleep quality and high risk of infection in this 
group (Huang and Zhao, 2020; Lai et al., 2020) may have been reduced 
by the protective effect of working on the preservation of routine and 
financial stability. 
Finally, most studies agreed that high income is a protective factor 
against anxiety during the pandemic (Fernández et al., 2020; Horesh 
et al., 2020; Lei et al., 2020; Pieh et al., 2020; Rodríguez-Rey et al., 2020; 
Shevlin et al., 2020; Shi et al., 2020). 
4.3.6. Education 
The level of education negatively correlated with anxiety in most 
studies (Alkhamees et al., 2020; Arafa et al., 2020; Gao et al., 2020; 
Islam et al., 2020; Newby et al., 2020; Paulino et al., 2020; Rodríguez- 
Rey et al., 2020; Shi et al., 2020; Solomou and Constantinidou, 2020; 
Zhao et al., 2020). Opposite results were found in one case, where the 
association between education and pro-active coping styles for anxiety 
(e.g., reading, physical activity, and seeking psychological support from 
family) was mitigated by a higher proportion of sleep disorders (Fu 
et al., 2020), and in another study where, with the increase in years of 
education, the level of anxiety also increased due to a majority of female 
participants (Moghanibashi-Mansourieh, 2020). 
4.3.7. Knowledge on COVID 
Ensuring that the general population receive enough timely and 
transparent information during Health Emergencies is critical for 
healthy psychological self-adaptation (Lasheras et al., 2020). This is 
underpinned by all of the studies included investigating this issue, where 
regular updates of the latest information were preferred by nearly all the 
respondents and were associated with lower levels of anxiety (Bäuerle 
et al., 2020; Cortés-Álvarez et al., 2020; Liu et al., 2020; Rodríguez-Rey 
et al., 2020; C. Wang et al., 2020a). Similarly, a low level of satisfaction 
or trust concerning the actions and information provided by the gov-
ernment correlated with high anxiety scores (Bäuerle et al., 2020; 
Cortés-Álvarez et al., 2020). 
Regarding the main source of information, one study found a non- 
significant tendency for increased anxiety levels when information 
was retrieved from less reliable sources, that is, social media, parents, 
and friends, followed by the Internet or the TV, newspapers and maga-
zines, and scientific journals (Cortés-Álvarez et al., 2020). On the con-
trary, a Saudi Arabian study found higher anxiety scores for those 
retrieving information from the World Health Organization versus local 
news (Alkhamees et al., 2020). This might reflect the high level of 
satisfaction with government reports in this population (Alkhamees 
et al., 2020), or an increased awareness of the pandemic severity in other 
areas, which could possibly lead to anticipated worry, as has occurred in 
the past (Liao et al., 2014). 
4.3.8. Epidemiological risk, clinical risk and worry about infection 
As expected, worry about infection of oneself or loved ones was 
common in the respondents and correlated strongly with anxiety (Choi 
et al., 2020; Elhai et al., 2020; Fernández et al., 2020; Huarcaya-Victoria 
et al., 2020; Islam et al., 2020; Lei et al., 2020; Liu et al., 2020; Newby 
et al., 2020; Paulino et al., 2020; Rodríguez-Rey et al., 2020; C. Wang 
et al., 2020a). People were also concerned that the health care system 
could not cope with the COVID-19 pandemic (Choi et al., 2020), its 
economic impact, and uncertainty about when the crisis is going to end 
(Newby et al., 2020; Rodríguez-Rey et al., 2020). In this sense, those 
who had negative perceptions regarding the pandemic (e.g. “the worst 
of the crisis has not yet passed”) or perceived threat of death from 
COVID-19 showed higher anxiety scores (Al Banna et al., 2020; Elhai 
et al., 2020; Liu et al., 2020). 
Similarly, high anxiety levels were found in respondents with certain 
epidemiological risk factors, such as exposure to other people at work 
(Shi et al., 2020), history of direct or indirect contact (Cortés-Álvarez 
et al., 2020; Shi et al., 2020; C. Wang et al., 2020a), having friends or 
relatives with COVID (Moghanibashi-Mansourieh, 2020; Özdin and 
Bayrak Özdin, 2020; Rodríguez-Rey et al., 2020), having a shortage of 
surgical masks for personal protection (Choi et al., 2020); as well as 
among those having COVID symptoms with no diagnosis (Alkhamees 
et al., 2020; Cortés-Álvarez et al., 2020; Fullana et al., 2020; Shi et al., 
2020) or a confirmed infection (Hyland et al., 2020; Paulino et al., 
2020). In this sense, only some studies, mostly Chinese, reported higher 
odds of anxiety in respondents located closer to the infection focus (Fu 
et al., 2020; Gao et al., 2020; Guo et al., 2020; Lei et al., 2020; Mog-
hanibashi-Mansourieh, 2020; Shi et al., 2020; Zhao et al., 2020). 
Finally, individuals with pre-existing chronic diseases or who re-
ported having poor health showed increased anxiety in most studies 
(Alkhamees et al., 2020; Gao et al., 2020; Guo et al., 2020; Horesh et al., 
2020; Lei et al., 2020; Newby et al., 2020; Ozamiz-Etxebarria et al., 
2020; Özdin and Bayrak Özdin, 2020; Palgi et al., 2020; Rettie and 
Daniels, 2020; Rodríguez-Rey et al., 2020; Shevlin et al., 2020; Solomou 
and Constantinidou, 2020; Stanton et al., 2020; C. Wang et al., 2020a). 
In some cases, living with people with chronic health problems had the 
same effect (Guo et al., 2020; Horesh et al., 2020; Hyland et al., 2020; 
Shevlin et al., 2020). Likewise, having a history of previous or current 
psychiatric illness increased anxiety levels (Alkhamees et al., 2020; 
Ayhan Başer et al., 2020; Fernández et al., 2020; Fullana et al., 2020; 
Newby et al., 2020; Özdin and Bayrak Özdin, 2020; Rettie and Daniels, 
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2020; Shi et al., 2020; Solomou and Constantinidou, 2020). 
4.3.9. Lifestyle determinants 
In most studies, participants had been put under mandatory quar-
antine, which can have a detrimental impact on mental health through 
alteration of routines and a reduction in social interactions (Guo et al., 
2020; Lei et al., 2020; Orellana and Orellana, 2020; Zhao et al., 2020). In 
fact, one study found that distress levels increased on a par with the 
amount of days without leaving the house (Rodríguez-Rey et al., 2020). 
This is consistent with previous research that concluded that the psy-
chological effects of quarantine are proportional to its duration 
(Hawryluck et al., 2004). 
Interestingly, those who remained physically active or took the op-
portunity to pursue hobbies showed reduced anxiety levels (Fu et al., 
2020; Fullana et al., 2020; Guo et al., 2020; Papandreou et al., 2020; 
Pieh et al., 2020; Rodríguez-Rey et al., 2020; Stanton et al., 2020). This 
can be explained by several physiological mechanisms: first, exercise 
helps maintain an adequate energy and brain oxygen supply; also, it can 
divert attention from the epidemic and reduce panic; and third, it is 
associated with better sleep quality (Fu et al., 2020). In this sense, 
practicing exercise can be a practical strategy to prevent sleep disorders, 
which are independent risk factors for anxiety during the pandemic 
(Guo et al., 2020; Papandreou et al., 2020; Stanton et al., 2020). Other 
adaptive coping strategies involve acceptance, active coping (e.g., sup-
port seeking, taking actions to improve the situation), and religion 
(Rettie and Daniels, 2020). 
Alcohol intake and smoking were associated with anxiety (Fernández 
et al., 2020; Papandreou et al., 2020; Stanton et al., 2020; Verma and 
Mishra, 2020). Similarly, unhealthy eating behaviors (e.g., food re-
straint, emotional and external eating, binge eating, snacking between 
meals, etc.) and following an unbalanced diet correlated with greater 
levels of anxiety in Greece and Spain (Fullana et al., 2020; Papandreou 
et al., 2020). 
4.3.10. Personality 
Higher scores on neuroticism, agreeableness, and conscientiousness 
were associated with more intense psychological distress, whereas 
higher levels on resilience and active coping skills during the quarantine 
had the opposite effect (Fernández et al., 2020). Similarly, individuals 
with high intolerance of uncertainty were more likely to use maladap-
tive coping strategies, such as self-distraction, denial, behavioral 
disengagement (e.g., giving up), which mediated increased rates of 
anxiety and depression (Rettie and Daniels, 2020). 
4.4. Clinic and public health implications 
Our study supports the need for integration of mental health con-
siderations into COVID-19 care, including the monitoring of psycho-
logical symptoms and social needs within the general population 
(Pfefferbaum and North, 2020). Anxiety is a normal reaction to a 
stressful situation, and the response to supportive interventions and 
coping strategies is generally positive (Huremović, 2019; Pfefferbaum 
and North, 2020). For example, increased anxiety levels during the 
pandemic are associated with fuller compliance with governmental 
measures and hygienic practices (Orellana and Orellana, 2020; Paulino 
et al., 2020). Nevertheless, anxiety about health matters can easily 
become excessive during an outbreak of infectious disease. At an indi-
vidual level, this can manifest as panic behaviors (repeated medical 
consultations, avoiding health care even if needed, hoarding of specific 
items, etc.); at a social level, it can lead to mistrust of public authorities, 
non-adherence to infection control measures, and stigmatization of 
particular groups (Asmundson and Taylor, 2020). 
Given that some of the factors correlating with anxiety have been 
clearly identified, efforts should be made to reduce their impact. First, 
strategies should be developed to ensure early diagnosis of mental 
health problems, especially among the most vulnerable groups herein 
described. In this sense, current guidelines of cognitive-behavioral 
therapy for generalized anxiety may benefit from incorporating intol-
erance of uncertainty and maladaptive coping as modifiable risk factors 
(Rettie and Daniels, 2020). Second, under strict lockdown and with the 
closure of schools, resources should be gathered for parents who have to 
continue working and cannot leave their children unsupervised. Third, 
social support networks should be enhanced and established within 
population subgroups to safeguard their mental wellbeing (Sim et al., 
2010). Similarly, basic (e.g., problem-solving, confrontation, family in-
terventions, relaxation techniques, etc.) and more complex psycho-
therapeutic interventions (e.g., cognitive-behavior therapy) could be 
delivered online or via telephone to counteract anxiety in the home 
environment. Fourth, authorities should make efforts to deliver timely, 
transparent, and comprehensive information to the community 
regarding the disease outbreak in order to decrease uncertainty about 
the disease. Fifth, strict confinement should be avoided whenever 
possible, providing individuals with the possibility of spending some 
time outdoors, especially for those who do not have a residence with 
open-air space. Likewise, exercising, pursuing leisure activities, and 
communicating frequently through telephone or online video should be 
encouraged in times of social isolation and confinement. Finally, 
alcohol, tobacco, and drug consumption should be discouraged and 
disincentivized, at the same time as resources are ensured for those 
suffering from an addiction in times when access to drugs is limited. 
4.5. Strengths and limitations 
To our knowledge, this is the second meta-analysis of all available 
studies of anxiety in the general population during the COVID-19 
outbreak. As a meta-analysis, it has greater power than any individual 
study to estimate more accurate rates of anxiety, by considering a much 
larger population drawn from across different countries. Moreover, this 
is the first study to systematically report all factors correlating with 
anxiety that have been identified so far during the COVID-19 pandemic, 
and to assess results with regard to the time of data collection within the 
epidemic curve in each country. 
However, there are some limitations that should be considered when 
interpreting our results. Firstly, only 8 out of the 21 countries included 
were subject to more than one study, and sometimes direct comparison 
between them was hindered by methodological differences (e.g., several 
anxiety scales). Even so, the use of different scales to assess anxiety was a 
major source of the heterogeneity in the prevalence rates reported by the 
studies. Secondly, all studies had particular constraints derived from the 
unusual circumstances surrounding the COVID-19 outbreak. These 
include randomization of the sample being rarely used (Choi et al., 
2020; Kazmi et al., 2020) and obtaining data via online surveys, which 
could entail selection biases such as oversampling of younger or more 
educated people (Moghanibashi-Mansourieh, 2020; Wang et al., 2020a). 
Also, the assessment of anxiety by self-reported scales rather than clin-
ical interviews might bias prevalence rates, because respondents may 
not respond truthfully, but in a socially acceptable way (Demetriou 
et al., 2015). Finally, all of the included studies were cross-sectional and 
may have assessed anxiety at different stages of the outbreak and after a 
different duration of quarantine. 
5. Conclusions 
Given an overall global prevalence of anxiety disorders estimated to 
be normally around 7.3%, our results suggest that rates of anxiety in the 
general population could be 3 times higher during the COVID-19 
outbreak. Therefore, several individual and population-level strategies 
should be implemented in order to preserve the mental wellbeing of 
vulnerable groups and decrease the impact of several modifiable factors 
associated with anxiety. 
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Bäuerle, A., Teufel, M., Musche, V., Weismüller, B., Kohler, H., Hetkamp, M., Dörrie, N., 
Schweda, A., Skoda, E., 2020. Increased generalized anxiety, depression and distress 
during the COVID-19 pandemic: a cross-sectional study in Germany. J. Public Health 
(Bangkok) 1–7. https://doi.org/10.1093/pubmed/fdaa106. 
Begg, C.B., Mazumdar, M., 1994. Operating characteristics of a rank correlation test for 
publication bias. Biometrics 50, 1088–1101. 
Bueno-Notivol, J., Gracia-García, P., Olaya, B., Lasheras, I., López-Antón, R., 
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